(GMT-05:00) Eastern Time (US & Canada)
45 minutes
Global supply chain disruptions are impacting every piece of the economy and the life sciences is no exception. From unavailability to longer lead times to significant price increases, life sciences companies are being forced to reckon with new levels of uncertainty that can impact business operations and business strategies. This panel will discuss how global supply chain disruptions have impacted their organization, how they have reacted, and how they are planning for the future.
Global supply chain disruptions are impacting every piece of the economy and the life sciences is no exception. From unavailability to longer lead times to significant price increases, life sciences companies are being forced to reckon with new levels of uncertainty that can impact business operations and business strategies. This panel will discuss how global supply chain disruptions have impacted their organization, how they have reacted, and how they are planning for the future.

Speakers

Edgar Lara Coronado - Director, Supply Chain Biologics, Bristol Myers Squibb
Laura Landriani - VP, Supply Chain and PPI, Thermo Fisher Scientific
Nicholas Holsman - CCO, Shorla Oncology
Patrick Berreby - Vice President, Supply Chain, Alnylam Pharmaceuticals
Tracks
Name Audience
Business Track